[Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
D000328:Adult; D000368:Aged; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D001127:Arginine Vasopressin; C007223:vasopressin, 1-deamino-4-Val-8-Arg-; D003894:Deamino Arginine Vasopressin; D014633:Valine
A diabetes insipidus kezelése synthetikus vasopressin-származékokkal (az 1-deamine 8-D-arginin vasopressin (DDAVP) és az 1-deamino-4-valin-8-D-arginin vasopressin (DVDAVP) hatása).